Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia

Department of Medicine, Divisions of Clinical Pharmacology and Cardiology, Division of Biometry, Duke University Medical Center, Durham, North Carolina.

OBJECTIVES. This study was performed to determine the incidence of symptomatic, sustained atrial fibrillation in a group of patients with paroxysmal supraventricular tachycardia. The effects of the mechanism of paroxysmal supraventricular tachycardia (atrioventricular [AV] node reentry vs. AV reentry through an accessory pathway) and heart rate during the tachycardia on the occurrence of atrial fibrillation were also assessed. BACKGROUND. There is a substantial incidence of atrial fibrillation in patients with paroxysmal supraventricular tachycardia, but the precise incidence and the factors that determine it are unknown. METHODS. One hundred sixty-nine patients with paroxysmal supraventricular tachycardia were followed up by regular clinic visits and transtelephonic electrocardiographic monitoring during symptomatic episodes of arrhythmia. The Kaplan-Meier product-limit method was used to estimate the proportion of patients remaining free of atrial fibrillation during the observation period. The Cox proportional hazards model was used to assess the effect of mechanism and heart rate during paroxysmal supraventricular tachycardia on the atrial fibrillation-free period. RESULTS. Thirty-two (19%) of the 169 patients had an episode of atrial fibrillation during a mean follow-up period of 31 months. The cumulative percent of patients experiencing an episode of atrial fibrillation was 6% within 1 month, 9% within 4 months and 12% within 1 year. The mechanism of paroxysmal supraventricular tachycardia was not associated with the time to occurrence of atrial fibrillation; the hazard ratio corresponding to classification in the AV node reentry group was 0.8 (p > 0.6). The heart rate during paroxysmal supraventricular tachycardia was not associated with the time to occurrence of atrial fibrillation; the hazard ratio associated with an increase in heart rate of 50 beats/min during the tachycardia was 1.15 (p > 0.5). CONCLUSIONS. This study suggests that atrial fibrillation will develop in approximately 12% of patients with paroxysmal supraventricular tachycardia during a 1-year follow-up period. The occurrence of atrial fibrillation is not related to the mechanism or heart rate of the paroxysmal supraventricular tachycardia.

This article has been cited by other articles:

				A. Shiroshita-Takeshita, H. Mitamura, S. Ogawa, and S. Nattel Rate-dependence of atrial tachycardia effects on atrial refractoriness and atrial fibrillation maintenance Cardiovasc Res, October 1, 2008; (2008) cvn249v2. [Abstract] [Full Text] [PDF]

				R. E. Eckart and L. M. Epstein Interventional Therapy for Atrial and Ventricular Arrhythmias Card. Surg. Adult, January 1, 2008; 3(2008): 1357 - 1374. [Full Text]

				C. Dimmer, T. Szili-Torok, R. Tavernier, T. Verstraten, and L. J. Jordaens Initiating mechanisms of paroxysmal atrial fibrillation Europace, January 1, 2003; 5(1): 1 - 9. [Abstract] [PDF]

				N. Bottoni, C. Tomasi, P. Donateo, G. Lolli, N. Muią, F. Croci, D. Oddone, C. Menozzi, and M. Brignole Clinical and electrophysiological characteristics in patients with atrioventricular reentrant and atrioventricular nodal reentrant tachycardia Europace, January 1, 2003; 5(3): 225 - 229. [Abstract] [Full Text] [PDF]

				S. D. Satti and L. M. Epstein Cardiologic Interventional Therapy for Atrial and Ventricular Arrhythmias Card. Surg. Adult, January 1, 2003; 2(2003): 1253 - 1270. [Full Text]

				M. M. Scheinman Mechanisms of atrial fibrillation: is a cure at hand? J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1687 - 1692. [Abstract] [Full Text] [PDF]

				Y.-J. Chen, S.-A. Chen, C.-T. Tai, Z.-C. Wen, A.-N. Feng, Y.-A. Ding, and M.-S. Chang Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fibrillation J. Am. Coll. Cardiol., September 1, 1998; 32(3): 732 - 738. [Abstract] [Full Text] [PDF]

				S.-A. Chen, C.-E. Chiang, C.-T. Tai, S.-H. Lee, C.-W. Chiou, K.-C. Ueng, Z.-C. Wen, C.-C. Cheng, and M.-S. Chang Longitudinal Clinical and Electrophysiological Assessment of Patients With Symptomatic Wolff-Parkinson-White Syndrome and Atrioventricular Node Reentrant Tachycardia Circulation, June 1, 1996; 93(11): 2023 - 2032. [Abstract] [Full Text]